Tyrosine Kinase Inhibitor as a new Therapy for Ischemic Stroke and other Neurologic Diseases: is there any Hope for a Better Outcome?

Publisher： Bentham Science Publishers

E-ISSN： 1875-6190|13|6|836-844

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.13, Iss.6, 2015-12, pp. : 836-844

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Spleen Tyrosine Kinase (Syk) in Human Disease, Implications for Design of Tyrosine Kinase Inhibitor Based Therapy

By  

Current Pharmaceutical Design, Vol. 10, Iss. 15, 2004-06 ,pp. : 1739-1744

Bentham Science Publishers

Access to resources Recommend Favorite

Small Molecule Tyrosine Kinase Inhibitors: The New Dawn for Cancer Therapy

By  

Letters in Drug Design & Discovery, Vol. 9, Iss. 1, 2012-01 ,pp. : 84-125

Bentham Science Publishers

Access to resources Recommend Favorite

New hope for neglected diseases

By Hale Victoria  

Expert Opinion on Emerging Drugs, Vol. 7, Iss. 2, 2002-10 ,pp. : 209-212

Informa Healthcare

Access to resources Recommend Favorite

Thrombolytic Therapy for Acute Ischemic Stroke

By Cornu C.  

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 4, 2001-04 ,pp. : 281-292

Adis International

Access to resources Recommend Favorite

Endovascular therapy of acute ischemic stroke

By Raychev Radoslav   Ovbiagele Bruce  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 6, 2011-04 ,pp. : 913-930

Informa Healthcare

Access to resources Recommend Favorite